VEGFA and neoplasm: Finally, in the univariate analysis (Cox model), tumor site (HR 1.86, CI 1.18–2.95, p = 0.08), pN (HR 1.63, CI 1.04–2.57, p = 0.03), pM (HR 2.89, CI 1.79–4.68, p < 0.0001), VEGF-A (HR 1.58, CI 1.01–2.48, p = 0.046), and the combination VEGF-AH/TRF2H (HR 1.66, CI 1.04–2.64, p = 0.032) were associated with an increased risk of disease recurrence (Table 2).